NEURALSTEM, INC. : First Patients Dosed in Ib Phase of ...
4-traders
ROCKVILLE, Md., June 25, 2012 /PRNewswire/ -- Neuralstem, Inc. announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety ...
First Patients Dosed in Ib Phase of Neuralstem's NSI-189 Trial in ...Sacramento Bee
all 7 news articles »
More...

LinkBack URL
About LinkBacks


Reply With Quote